Status:

COMPLETED

A 12-week, Multicentric Study to Evaluate the Safety and Efficacy of Bisoprolol in Filipino Hypertensive Subjects With Diabetes

Lead Sponsor:

Merck KGaA, Darmstadt, Germany

Collaborating Sponsors:

Merck Inc., Philippines

Conditions:

Hypertension

Eligibility:

All Genders

18+ years

Phase:

PHASE4

Brief Summary

The aim of this 12-week, multicenter, interventional, prospective, open-label and single-arm study is to evaluate the safety and efficacy of 5 milligram per day (mg/day) and 10 mg/day bisoprolol in Fi...

Eligibility Criteria

Inclusion

  • Adult subjects with hypertension, either newly diagnosed or treated but currently uncontrolled as defined by Joint National Committee (JNC) 7 for subjects with Type 2 diabetes mellitus (T2DM) (that is, greater than or equal to \[\>=\] 130/80 mmHg)
  • Aged at least 18 years old
  • Diagnosed with T2DM and already on anti-diabetic therapy, and with glycosylated hemoglobin of less than 7 percent

Exclusion

  • Subjects who were already on beta-blocker therapy at the time of recruitment
  • Subjects with heart rate of at most 60 beats per minute (bpm) at rest
  • Subjects with secondary hypertension, congenital heart disease, coronary artery disease, peripheral arterial disease or congestive heart failure in any stage
  • Subjects with coronary conduction disorders (bundle branch block)
  • Subjects with signs of definitive target organ damage consistent with World Health Organization (WHO) Stage III or with severe renal or hepatic disease
  • Subjects who are pregnant or expect to be pregnant within the 24-week study period
  • Subjects on oral contraceptives
  • Subjects with asthma or a history of asthma
  • Subjects with documented severe renal disease
  • Subjects on anti-neoplastic drugs

Key Trial Info

Start Date :

December 1 2009

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 1 2011

Estimated Enrollment :

125 Patients enrolled

Trial Details

Trial ID

NCT01190436

Start Date

December 1 2009

End Date

December 1 2011

Last Update

January 30 2017

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Research Site

Manila, Philippines

A 12-week, Multicentric Study to Evaluate the Safety and Efficacy of Bisoprolol in Filipino Hypertensive Subjects With Diabetes | DecenTrialz